CNQ · RVV.CN
Revive Therapeutics Ltd.
CA$0.02-CA$0.01 (-25.0%)
Revive Therapeutics Ltd.’s quoted price sits in the lower half of its reported 52-week range, 81.25% below the high.
Loading market information…
NEO · TILT.NE · CAD
Stock price, earnings
Quote as of Nov 14, 2025, 09:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
TILT Holdings Inc.’s quoted price sits in the upper half of its reported 52-week range, 33.33% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow TILT Holdings Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
TILT Holdings Inc. is a prominent player in the global cannabis industry, with operations spanning the United States, Canada, Israel, Mexico, South America, and the European Union. The company structures its diverse activities across three primary divisions: Cannabis, Accessories, and Other. Its cannabis segment encompasses the full lifecycle from cultivation and production to extraction and sale of various cannabis products, notably employing greenhouse cultivation and CO2 extraction techniques. Furthermore, TILT specializes in processing and delivering a wide range of medical cannabis products, including raw flower, infused goods, concentrates, topicals, tinctures, vape cartridges, and syringes. The Accessories division focuses on the manufacturing and distribution of electronic and non-nicotine devices and systems. TILT Holdings Inc. maintains its corporate headquarters in Phoenix, Arizona.
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 12:12 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Q4 2023 | Mar 14, 2024 | -CA$0.08-695.2% vs estimate | CA$49.70M-12.79% vs estimate |
|---|
| Q3 2023 | Nov 13, 2023 | -CA$0.02-100.0% vs estimate | CA$60.59M+4.49% vs estimate |
|---|
THE ANALYST VIEW
1 ratings in the current snapshot. Strong buy and strong sell are grouped with buy and sell.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$0.02-CA$0.01 (-25.0%)
Revive Therapeutics Ltd.’s quoted price sits in the lower half of its reported 52-week range, 81.25% below the high.
CA$0.01CA$0.00 (0.0%)
1933 Industries Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.03$0.00 (0.0%)
CordovaCann Corp.’s quoted price sits in the lower half of its reported 52-week range, 57.14% below the high.
CA$0.07-CA$0.01 (-7.14%)
Restart Life Sciences Corp.’s quoted price sits in the lower half of its reported 52-week range, 51.85% below the high.
$1.03-$0.02 (-1.9%)
XORTX Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 71.39% below the high.
CA$0.03CA$0.00 (0.0%)
City View Green Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 76.92% below the high.
CA$0.04-CA$0.01 (-12.5%)
Lifeist Wellness Inc.’s quoted price sits in the lower half of its reported 52-week range, 53.33% below the high.
CA$0.01+CA$0.01 (+100.0%)
Appili Therapeutics Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
